Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study
Topline results from Phase 3 ICONIC-ADVANCE 1&2studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe PsO
Results pave the way to initiate the first-ever head-to-head study (ICONIC-ASCEND) seeking to demonstrate the superiority of a pill versus injectable biologic in moderate-to-severe PsO
Read MoreUnveiled revolutionary AI Nose for robotics application, inviting global robotics companies to join Ainos Alliance in shaping the future of smell-enabled robots
Advanced VELDONA® development with key Japan patent, Taiwan Tanabe partnership, and IRB approval for Sjögren's syndrome clinical study
Read More
The School of Engineering and Sciences at Tecnologico de Monterrey has unveiled its Food Security and Nutrition Flagship Project in Mexico, an applied research initiative aimed at transforming the country's food and nutrition landscape.
Read MoreWith this certification, Nexus Cognitive strengthens its position as a trusted partner for automotive suppliers and OEMs, delivering AI-driven data integration, governance, and interoperability solutions to accelerate digital transformation and supply chain innovation.
Read More